Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: CANCER-ASSOCIATED THROMBOSIS, . Treffer: 8
2022
Englisch, C; Konigsbrugge, O; Nopp, S; Moik, F; Quehenberger, P; Preusser, M; Pabinger, I; Ay, C
Antithrombin Activity and Association with Risk of Thrombosis and Mortality in Patients with Cancer
INT J MOL SCI. 2022; 23(24): 15770
Doi: 10.3390/ijms232415770
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Khorana, AA; Mackman, N; Falanga, A; Pabinger, I; Noble, S; Ageno, W; Moik, F; Lee, AYY
Cancer-associated venous thromboembolism.
Nat Rev Dis Primers. 2022; 8(1): 11
Doi: 10.1038/s41572-022-00336-y
Web of Science
PubMed
FullText
FullText_MUG
Moik, F; Ay, C
Venous and arterial thromboembolism in patients with cancer treated with targeted anti-cancer therapies
THROMB RES. 2022; 213: S58-S65.
Doi: 10.1016/j.thromres.2022.01.004
Web of Science
PubMed
FullText
FullText_MUG
2020
Moik, F; Ay, C; Pabinger, I
Risk prediction for cancer-associated thrombosis in ambulatory patients with cancer: past, present and future.
Thromb Res. 2020; 191 Suppl 1:S3-S11
Doi: 10.1016/S0049-3848(20)30389-3
Web of Science
PubMed
FullText
FullText_MUG
Moik, F; Pabinger, I; Ay, C
How I treat cancer-associated thrombosis.
ESMO Open. 2020; 5(1):e000610
Doi: 10.1136/esmoopen-2019-000610
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
Muster, V; Gary, T
Incidence, Therapy, and Bleeding Risk-Cancer- Associated Thrombosis in Patients with Glioblastoma.
Cancers (Basel). 2020; 12(6):
Doi: 10.3390/cancers12061354
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2019
Grilz, E; Mauracher, LM; Posch, F; Königsbrügge, O; Zöchbauer-Müller, S; Marosi, C; Lang, I; Pabinger, I; Ay, C
Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancer.
Br J Haematol. 2019; 186(2): 311-320.
Doi: 10.1111/bjh.15906
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2018
Mauracher, LM; Posch, F; Martinod, K; Grilz, E; Däullary, T; Hell, L; Brostjan, C; Zielinski, C; Ay, C; Wagner, DD; Pabinger, I; Thaler, J
Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients.
J Thromb Haemost. 2018; 16(3):508-518
Doi: 10.1111/jth.13951
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG